50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
CEO of biggest PE firm predicts “social unrest” (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Goldman Sachs Alum Sounds Alarm on "Next US Crisis" (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Gold is about to SOAR – here’s what you need to do (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
CEO of biggest PE firm predicts “social unrest” (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Goldman Sachs Alum Sounds Alarm on "Next US Crisis" (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Gold is about to SOAR – here’s what you need to do (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
CEO of biggest PE firm predicts “social unrest” (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Goldman Sachs Alum Sounds Alarm on "Next US Crisis" (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Gold is about to SOAR – here’s what you need to do (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
S&P 500   3,647.29
DOW   29,134.99
QQQ   274.48
Layoffs Aren't the Solution to Your Profitability Crisis. Here's the Simple 4-Step Process You Should Be Following Instead.
CEO of biggest PE firm predicts “social unrest” (Ad)
Is There Value In These Growth Stocks?
MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
Goldman Sachs Alum Sounds Alarm on "Next US Crisis" (Ad)
Build A Better Tech Portfolio With Jabil Inc.
US stocks end mixed a day after Dow entered a bear market
Gold is about to SOAR – here’s what you need to do (Ad)
Autodesk Is A Mature Company Still Acting Like A Growth Stock
Leaks on Russian gas pipelines raise concerns about sabotage
OTCMKTS:MBGNF

Many Bright Ideas Technologies - MBGNF Stock Forecast, Price & News

$0.11
0.00 (0.00%)
(As of 09/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.11
$0.11
50-Day Range
$0.11
$0.11
52-Week Range
$0.04
$1.00
Volume
N/A
Average Volume
4,936 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MBGNF stock logo

About Many Bright Ideas Technologies (OTCMKTS:MBGNF) Stock

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. Many Bright Ideas Technologies Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Receive MBGNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Many Bright Ideas Technologies and its competitors with MarketBeat's FREE daily newsletter.

MBGNF Stock News Headlines

Is it Still Safe to Own Bright Horizons (BFAM)?
Bright MLS June Mid-Atlantic Market Report
Biolase Names Jennifer Bright Finance Chief
Bright Green CEO Ed Robinson Steps Down
Med BioGene Inc (MBGNF)
See More Headlines
Receive MBGNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Many Bright Ideas Technologies and its competitors with MarketBeat's FREE daily newsletter.

MBGNF Company Calendar

Last Earnings
11/29/2013
Today
9/28/2022

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MBGNF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Iain Weir-Jones FGS
    P.Eng., Ph.D., Chairman & CEO
  • Mr. Ibrahim Ghobrial
    Chief Financial Officer













MBGNF Stock - Frequently Asked Questions

How have MBGNF shares performed in 2022?

Many Bright Ideas Technologies' stock was trading at $0.11 at the beginning of the year. Since then, MBGNF shares have decreased by 3.8% and is now trading at $0.1058.
View the best growth stocks for 2022 here
.

How were Many Bright Ideas Technologies' earnings last quarter?

Many Bright Ideas Technologies Inc. (OTCMKTS:MBGNF) announced its quarterly earnings results on Friday, November, 29th. The company reported ($0.01) earnings per share for the quarter.

What is Many Bright Ideas Technologies' stock symbol?

Many Bright Ideas Technologies trades on the OTCMKTS under the ticker symbol "MBGNF."

How do I buy shares of Many Bright Ideas Technologies?

Shares of MBGNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Many Bright Ideas Technologies' stock price today?

One share of MBGNF stock can currently be purchased for approximately $0.11.

How can I contact Many Bright Ideas Technologies?

Many Bright Ideas Technologies' mailing address is 598 East Kent Avenue South, Vancouver, BC V5X. The official website for the company is www.medbiogene.com. The company can be reached via phone at (604) 732-7332.

This page (OTCMKTS:MBGNF) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.